Live Breaking News & Updates on Proteomics Clinical Applications

Stay updated with breaking news from Proteomics clinical applications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Diagnosing Progressive Pulmonary Fibrosis

Renowned medical professionals and experts congregated in Milan to explore the current and future prospects of diagnosing PPF. ....

University Hospital , New York , United States , Zuid Holland , United Kingdom , Marliess Wijsenbeek , Elisabeth Robertson , Michael Kreuter , Anna Podolanczuk , Weill Cornell Medical College , European Respiratory Society , Lung Center At University Hospital , New York City , Lung Center , Interstitial Lung Disease Centre , Erasmus University Medical Centre , Medscape Medical , Practice Guideline , Idiopathic Pulmonary Fibrosis , Lung Fibrosis , Pulmonary Fibrosis , Ibrosis Pulmonary , Interstitial Lung Disease , Healthcare And Medical Technology , Ealth And Medical Tech , Ealth And Med Tech ,

Aspira Women's Health Shares Climb on Nasdaq Compliance

By Dean Seal Shares of Aspira Women's Health were higher after the company regained compliance with Nasdaq's listing rules. The stock was up 21% at $6 in. ....

United States , Aspira Women Health , Aspira Women , Nasdaq Stock Market , Dean Seal , Article Normal , Biotechnology Services , Scientific Research Services , Healthcare Life Sciences , Business Consumer Services , Medical Research Services , Healthcare Support Services , Diagnostic Medical Research Services , Political General News , Demographic Health , Women Amp 39s Health , Aspira Women Amp 39s Health , General News , Life Sciences , Consumer Services ,

Challenges in China spell trouble for Illumina, 10x and others

China’s recovery from its zero-COVID policy has failed to gain the momentum expected, with many experts predicting a slow or even negative growth rate. A slower economy, combined with a push toward self-reliance, bodes poorly for diagnostics manufacturers in the U.S. who may find themselves not just shut out of the huge market but facing stiffer competition around the globe. Further, policies designed to build a domestic next-generation sequencing industry have created headwinds for San Diego-based Illumina Inc. and others, noted Kyle Mikson and Alex Vukasin of Canaccord Genuity in an in-depth report. ....

Canaccord Genuity , Kyle Mikson , Alex Vukasin , San Illumina Inc , San Diego Based Illumina , Next Generation Sequencing , Spatial Biology , Single Cell Analysis , Thermo Fisher Scientific Inc ,

Aspira Women's Health Shares Rise 10% After Sample-Procurement Deal

By Chris Wack Aspira Women's Health shares were up 10%, to $4.39, after the diagnostic company entered into a material transfer agreement with The University. ....

Chris Wack , University Of Oxford , Aspira Women Health , Article Normal , Biotechnology Services , Scientific Research Services , Healthcare Life Sciences , Business Consumer Services , Medical Research Services , Healthcare Support Services , Diagnostic Medical Research Services , Financial Performance , Share Price Movement Disruptions , Ownership Changes , Acquisitions Mergers Shareholdings , Corporate Actions , Corporate Industrial News , Political General News , Demographic Health , Women Amp 39s Health , Equity Markets , Commodity Financial Market News , Content Types , Factiva Filters , C Amp Ampe Exclusion Filter , C Amp Ampe Industry News Filter ,

Bruker to acquire Phenomex for $108M in cash

Bruker Corp. signed a definitive agreement to acquire functional cell biology company Phenomex for $108 million as part of its Project Accelerate 2.0 strategy, which increases focus on the company’s emerging proteomics and spatial biology business. Bruker offered $1 per share, a 150% premium over the 40 cents per share closing price of Phenomex stock on Aug. 16. The all-cash transaction is slated to close in the fourth quarter of 2023. ....

Bruker Corp , Project Accelerate , Bruker Corp , Phenomex Inc ,